Results 11 to 20 of about 4,842 (209)

Improving the Characteristics of Fruiting Bodies in Lentinus edodes: The Impact of Rolipram-Induced cAMP Modulation. [PDF]

open access: yesMetabolites
Background: Strains XG04 and XGT2 of Lentinus edodes (Berk.) Singer demonstrate a high degree of genomic similarity, with XGT2 representing a systematic selection of XG04 and exhibiting enhanced phenotypic traits.
Li H   +6 more
europepmc   +2 more sources

Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV [PDF]

open access: greenExperimental Neurology, 2007
Rolipram, a specific inhibitor of the phosphodiesterase IV (PDE IV), has recently been shown to exert neuroprotective effects in an Alzheimer transgenic mouse model and in hypoxic-ischemic damage in the rat brain. It activates the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway and it inhibits ...
Lichuan Yang   +3 more
openalex   +4 more sources

Rolipram as a discriminative stimuli : Transfer to phosphodiesterase inhibitors.

open access: goldJapanese Journal of Pharmacology, 1987
Rats were trained to discriminate (+/-)-rolipram (0.32 mg/kg, i.p.) from saline in a two-lever food-reinforced drug discrimination procedure (FR 10). (+/-)-Rolipram served as a drug discriminative stimulus, and its discrimination was readily established with a mean of 42 training sessions to achieve criterion performance (at least 80% correct response ...
Tsuneyuki Yamamoto   +2 more
  +6 more sources

Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity

open access: yesNeurobiology of Disease, 2007
Activity of c-AMP responsive element-binding protein (CREB) is decreased in Huntington’s disease (HD). Such decrease was also described by our group in the quinolinic acid lesion model of striatal excitotoxicity.
Zena DeMarch   +5 more
doaj   +5 more sources

Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies

open access: yesFrontiers in Aging Neuroscience, 2015
AimSystemic pharmacotherapies have limitation due to blood-labyrinth barrier, so local delivery via the round window membrane opens a path for effective treatment.
Rudolf Glueckert   +2 more
exaly   +3 more sources

Inhibition of PDE-4 isoenzyme attenuates frequency and overall contractility of agonist-evoked ureteral phasic contractions. [PDF]

open access: yesPharmacol Res Perspect
The aim of this study was to investigate the functional role of phosphodiesterase enzymes (PDE) in the isolated porcine ureter. Distal ureteral strips were mounted in organ baths and pre‐contracted with 5‐HT (100 μM).
Lim I   +4 more
europepmc   +2 more sources

Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease

open access: yesNeurobiology of Disease, 2008
We have previously showed that rolipram, a phosphodiesterase type IV inhibitor, displays a neuroprotective effect in a rat quinolinic acid model of HD [DeMarch Z., Giampa C., Patassini S., Martorana A., Bernardi G.
Zena DeMarch   +4 more
exaly   +2 more sources

A functional aged human iPSC-cortical neuron model recapitulates Alzheimer's disease, senescence, and the response to therapeutics. [PDF]

open access: yesAlzheimers Dement
Abstract INTRODUCTION The degeneration of cortical layers is associated with cognitive decline in Alzheimer's disease (AD). Current therapies for AD are not disease‐modifying, and, despite substantial efforts, research and development for AD has faced formidable challenges.
Gallo LH   +10 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy